Bone safety with risedronate: histomorphometric studies at different dose levels and exposure.

Recker, R R; Ste-Marie, L-G; Chavassieux, P; McClung, M R; Lundy, M W

Recker, R R; Ste-Marie, L-G; Chavassieux, P; McClung, M R; Lundy, M W.

Affiliation

Recker RR; Osteoporosis Research Center, Creighton University School of Medicine, 601 N. 30th Street Suite 4820, Omaha, NE, 68131, USA, rrecker@creighton.edu.

Osteoporos Int ; 26(1): 327-37, 2015 Jan.

Article in En | MEDLINE | ID: mdl-25304456

Subject(s)

Bone Density Conservation Agents/administration & dosage; Etidronic Acid/analogs & derivatives; Osteoporosis, Postmenopausal/drug therapy; Aged; Biopsy; Bone Density/drug effects; Bone Density Conservation Agents/adverse effects; Bone Density Conservation Agents/pharmacology; Bone Density Conservation Agents/therapeutic use; Bone Remodeling/drug effects; Bone and Bones/pathology; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Etidronic Acid/administration & dosage; Etidronic Acid/adverse effects; Etidronic Acid/pharmacology; Etidronic Acid/therapeutic use; Female; Humans; Middle Aged; Multicenter Studies as Topic; Osteoporosis, Postmenopausal/pathology; Osteoporosis, Postmenopausal/physiopathology; Randomized Controlled Trials as Topic; Risedronic Acid

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Etidronic Acid / Bone Density Conservation Agents Type of study: Clinical_trials / Qualitative_research / Systematic_reviews Limits: Aged / Female / Humans / Middle aged Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google